| 1. | Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era. | |
| Pages 1-8 | ||
| Emad A Abdelhady | ||
| 2. | B-cell-receptor-targeted therapy in CLL | |
| Pages 9-18 | ||
| Haitham M AbdelBary | ||
| 3. | Current issues in chronic graft versus host disease | |
| Pages 19-30 | ||
| Amr M ElGhammaz | ||
| 4. | Fibrinogen as a replacement therapy in bleeding disorder | |
| Pages 31-35 | ||
| Rasha M Mohamed Said | ||
| 5. | Secondary Monoclonal Gammopathy of Undetermined Significance: A Sign Of Cure Or A Harbinger Of Relapse. | |
| Pages 36-40 | ||
| Alia M. Saeed | ||
| 6. | Epigenetics in Hematological Malignancies | |
| Pages 41-50 | ||
| Mostafa K ElRazzaz | ||
| 7. | Prevention of venous thromboembolism in cancer patients | |
| Pages 51-57 | ||
| Haydi M Mohamed | ||
